Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

The US Food and Drug Administration has issued a single observation for Cipla’s Bommasandra manufacturing facility.

by Team Small News | May 31, 2025 | Cipla, Pharma

The US Food and Drug Administration (USFDA) has issued a single observation for Cipla’s Bommasandra facility, which is a pharmaceutical manufacturing plant located in Karnataka, India. The observation was made after the USFDA conducted an inspection of the...

Pfizer, AstraZeneca, and Daiichi Sankyo unveil groundbreaking cancer treatment findings at the 2025 ASCO Annual Meeting, as reported on geneonline.com.

by Team Small News | May 31, 2025 | Pfizer, Pharma

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting featured significant presentations from major pharmaceutical companies, including Pfizer, AstraZeneca, and Daiichi Sankyo. The meeting highlighted new data on innovative cancer treatments, showcasing...

A 68-year-old woman undergoes successful Reverse Total Shoulder Replacement Surgery at Fortis Hospital Nagarbhavi

by Team Small News | May 31, 2025 | Fortis, Pharma

A 68-year-old woman, Mrs. Basanti, was successfully treated for severe shoulder arthritis at Fortis Hospital Nagarbhavi in Bangalore. She had been suffering from intense pain and limited mobility in her right shoulder for over two years, which affected her daily...
Piramal Pharma Boosts Biologics Production Capacity to Accelerate New Medicine Development – geneonline.com

Piramal Pharma Boosts Biologics Production Capacity to Accelerate New Medicine Development – geneonline.com

by Team Small News | May 31, 2025 | Pharma, Piramal Pharma

Piramal Pharma, a leading global pharmaceutical company, has announced the expansion of its biologics manufacturing infrastructure to enhance its drug development capabilities. This strategic move is aimed at strengthening the company’s position in the...

Pfizer’s Oral Obesity Medication Failure: A Sign of Underlying Issues in the Company’s Pipeline – Seeking Alpha

by Team Small News | May 30, 2025 | Pfizer, Pharma

Pfizer’s recent failure to gain FDA approval for its oral obesity drug, danuglipron, has raised concerns about the company’s research and development pipeline. Danuglipron was expected to be a major contributor to Pfizer’s revenue growth, but its...

Natco Pharma’s Q4 net profit sees 5% year-over-year increase, reaching ₹406 crore.

by Team Small News | May 30, 2025 | Natco, Pharma

Natco Pharma Ltd, an Indian multinational pharmaceutical company, reported a 5% increase in consolidated net profit for the quarter ended March 31, 2025, with a net profit of ₹406 crore compared to ₹386.3 crore in the same period last year. The company’s...
« Older Entries

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress